SCALE UP AND POSTAPPROVAL CHANGES (SUPAC) GUIDANCE FOR INDUSTRY: A REGULATORY NOTE

Journal Title: International Journal of Drug Regulatory Affairs - Year 2017, Vol 5, Issue 1

Abstract

In today scenario, as per market demand there is definitely carry out an increment or decrease in production, this is called SUPAC. Different guidelines are provided for those different types of SUPAC in by different regulatory authority for manufacturing of product. Here SUPAC guidelines for USFDA are elaborated for production in this review article.

Authors and Affiliations

Mounica N. V. N. , Sharmila Reddy V, Evangeline L, Nagabhushanam M. V. , Nagarjunareddy D, Brahmaiah B.

Keywords

Related Articles

STEPS FOR SUCCESS IN SOURCING OF HARD GELATIN CAPSULES FOR PHARMACEUTICAL USE

The sourcing of raw Gelatin for manufacturing hard Gelatin Capsules is a very critical function. It involves a thorough quality audit of the suppliers. The most critical audit points are: source of Gelatin used, quality...

REVIEW ON OCULAR DRUG DELIVERY SYSTEM AND ITS DEVICES

Ocular drug delivery system for the treatment of eye diseases has become popular and feasible in the past few years. Improving ocular contact time, enhancing corneal permeability and site specificity are the key points f...

FEEBLE REGULATORY AFFAIRS WEAKEN THE BACKBONE OF INDIAN DRUG INDUSTRIES

India is emerging as a global outsourcing power house in almost all fields including Drugs and Pharmaceutical sector. Now it becomes a hub to conduct clinical trials and contract researches. Pharmaceutical industry curre...

COMPARATIVE STUDY OF REGULATORY REQUIREMENTS AND REGISTRATION PROCESS OF GENERIC DRUGS IN JAPAN AND CHINA

A Generic Product must meet the standards established by Pharmaceutical Medical Device Agency (PMDA) & China Food and Drug Administration (CFDA) to be approved for marketing in Japan and China respectively. This study co...

A COMPREHENSION STUDY ON REGULATION OF HERBAL DRUGS IN USA, EUROPEAN UNION AND INDIA

The present study reviews the regulations of herbal drugs in the EU, US and India and throws light upon issues related to their clinical trials. Herbal drugs have been used for a long time in different systems of health...

Download PDF file
  • EP ID EP326650
  • DOI 10.22270/ijdra.v5i1.192
  • Views 171
  • Downloads 0

How To Cite

Mounica N. V. N. , Sharmila Reddy V, Evangeline L, Nagabhushanam M. V. , Nagarjunareddy D, Brahmaiah B. (2017). SCALE UP AND POSTAPPROVAL CHANGES (SUPAC) GUIDANCE FOR INDUSTRY: A REGULATORY NOTE. International Journal of Drug Regulatory Affairs, 5(1), 13-19. https://europub.co.uk/articles/-A-326650